Propofol has become a popular intravenous agent for induction and maintenance of anaesthesia in recent years. Desirable pharmacokinetic properties and a favourable side-effect profile are positive features of the drug. However, reports of abnormal muscle movements, abnormal posturing and convulsive activity, related to the use of propofol, continue to appear. We report two cases of seizures related to the use of propofol, and follow with a review of the relevant literature.
CASE 2
A healthy male of 24 years presented, fasted, to a day surgery centre for elective extraction of four wisdom teeth.
He had had two previous operations, a tonsillectomy as a child and a mediastinoscopy two years previously, following which sarcoidosis was diagnosed.
Following this diagnosis, he had taken corticosteroids for several months, but on discontinuing the steroids, he had remained well. To the best of his knowledge he had had no difficulty with previous anaesthetics. There had been a respiratory infection one month prior to this procedure, but this had completely resolved. He was allergic only to bee stings. There was no prior history of epilepsy. He had sustained a minor head injury, an episode of concussion, some years previously in a motor vehicle accident. Physical examination revealed a fit afebrile 83 kg man with a soft systolic murmur at the left sternal edge, and no other abnormality.
No premedication was given. An intravenous cannula was inserted. Datex Cardiocap monitor (Datex Instrumentarium Corp.) and ECG leads were attached. The non-invasive blood pressure monitor was set to cycle at three minute intervals, and EtC0 2 , arterial saturation, Fj02 and FjN 2 0 were continuously monitored; a nerve stimulator (Fisher and Paykel) was connected. He was preoxygenated, given midazolam 1 mg and fentanyl 100 p,g intravenously. After a delay of several minutes, propofol was administered slowly, 250 mg being required to produce unconsciousness. Following test ventilation, he was given vecuronium 5 mg and ventilated for three to four minutes with 3% enflurane and 60% nitrous oxide and 40% oxygen. Prior to laryngoscopy he was given a further 60 mg of propofol.
The trachea was sprayed with 100 mg of 10% lignocaine and following intubation, the enflurane concentration was reduced to 1%, to 0.8% fOllowing the removal of the first tooth, 0.6% on removal of the second and 0.4% on removal of the third. During the operation, the patient was ventilated at a tidal volume of 800 ml and a rate of 10 breaths/minute. The surgeon administered 2.5 ml of 0.25 % bupivacaine and adrena-line 1:400,000 to the base of each wisdom tooth prior to extraction. During these injections no adverse events were witnessed. End-tidal C02 remained in the range 30 to 40 mmHg throughout and arterial saturation was never less than 97!rJo. Systolic blood pressure ranged between 170 and 90 mmHg throughout.
At the end of the procedure, residual neuromuscular blockade was reversed and following removal of a throat pack, the nitrous oxide and enflurane were discontinued and the patient was ventilated on 100% oxygen. As the patient opened his eyes and began adequate spontaneous ventilation he was extubated: within one minute while still breathing oxygen his limbs began to shake violently. For a few seconds, it was thought this might simply have been an exaggerated muscle tremor on recovery from enflurane. However, the patient, having opened his eyes to command less than one minute before, was now unresponsive to vocal stimuli, and the limb movements resembled the tonic/ clonic movements of a grand mal convulsion.
The patient was given midazolam 3 mg intravenously. No change in the convulsive movements was noted. Arterial saturations had been 99!rJo and 100!rJo just prior to the movements starting, and the oxygen analyzer showed an inspired oxygen concentration of 98!rJo. The patients' ventilation could be assisted with bag and mask. At no stage did he become clinically cyanosed.
As midazolam made no impact on the' 'convulsion", thiopentone 75 mg was given intravenously and the convulsion ceased. Within several minutes the patient opened his eyes. He was unaware of recent past events.
A decision was made to transfer the patient by ambulance to Woden Valley Hospital. While awaiting the ambulance a further convulsive episode occurred several minutes later. Again the patient's ventilation was assisted, and following 75 mg of thiopentone intravenously the episode ceased. Once he regained consciousness he was informed he had apparently had another convulsion and an infusion of phenytoin 250 mg was commenced. A third similar episode occurred as he was being placed in the ambulance. This convulsion ended following a further thiopentone 50 mg intravenously.
No portable monitoring devices, apart from a manual sphygmomanometer cuff and an ECG were available for use during transport. The patient continued breathing oxygen via mask during the transfer and was accompanied by the author. Clinical indications of his condition were relied upon during this period. Emergency drugs and equipment required for anaesthesia, paralysis, intubation and artificial ventilation were carried. No adverse incident occurred in transit.
Shortly after arrival at Woden Valley Hospital, some 20 minutes after leaving the Day Surgery Centre, a fourth convulsive episode occurred and this again termination after 50 mg thiopentone intravenously. A phenytoin 500 mg infusion was commenced.
While this phenytoin was running in, three more convulsive episodes occurred and again ceased after small intravenous boluses of thiopentone. No further convulsive episodes occurred after a total of phenytoin 750 mg had been administered.
All convulsive episodes occurred while the patient was breathing oxygen. His ventilation was assisted on each occasion with bag and mask. Following each convulsive episode, the patient regained consciousness and appeared to have no knowledge of events during the fit.
On arrival blood glucose, serum sodium, potassium, calcium, chloride, phosphate and magnesium were all normal. A CT scan of the head was normal and a subsequent EEG showed no epileptic focus. The patient remained on oral anticonvulsants for 24 hours postoperatively, but in the absence of further fitting, these were withdrawn by the neurologist. Review of the hospital case notes for the anaesthesia for mediastinoscopy showed prior exposure to thiopentone, fentanyl, enflurane and N 2 0 and no convulsions.
Six months following discharge the patient remains well.
These authors have witnessed myoclonic jerking, extra-pyramidal movements, chloreoathetosis, opisthotonos, petit mal and grand mal convulsions and muscle tremors on recovery from general anaesthesia and are of the opinion that the clinical picture exhibited by this patient most closely resembled grand mal convulsions.
The question of transport from a Day Surgery facility to a major hospital arose in the second case. Given the lack of availability of more modern monitoring equipment in this particular case, perhaps Day Surgery Centres should be equipped at least with an additional battery-operated pulse oximeter, to facilitate monitoring during transfer to a major hospital if required.
DISCUSSION

Types oj "Seizures" Associated With Propojo/
Many types of reactions have been reported in association with the use of propofol. Over the past few years a total of around 50 published case reports have described instances of twitching, truncal shaking\ hypertonia, myoclonus, dystonia, choreoathetosis 2 , opisthotonos 3 . 7 , and various types of convulsions, including grand mal convulsions. It is interesting that most reports of opisthotonos as a complication of anaesthesia agents have occurred during the last seven years, related to the use of propofol 6 ,9,1O.
The extent to which these purported side-effects of propofol represent a spectrum relating to single underlying mechanism, or a different series of mechanisms, is undetermined. Alternative mechanisms such as other drugs used concurrently causing the seizure l \ withdrawal effects in patients on regular anticonvulsant medication l " vasovagal episodes, respiratory alkalosis 13 , or cardiac arrhythmia l \ may explain some of the case reports; however it is hard to deny that a neurological side-effect of propofol is being slowly uncovered-albeit a side-effect with a very low incidence, Great variability has also been noted in the timing of these excitatory effects-on induction l ', immediately after anaesthesia l2 ,1\ and delayed I2 ,17.19. Some of the cases of delayed convulsions have occurred after seemingly well patients have left hospital after day surgery 1 7.
The early animal studies of propofol found no evidence of seizure activity related to this drug 20 .
The first reports of reactions in humans appeared in 1987 16 ,21.23, soon after the introduction of the drug into clinical practice. Reactions have occurred following major or minor l2 surgery, of long or short duration, after small or large doses, in patients who have epilepsyI2,24 and in those who do not.
Incidence
It is difficult to quantify the incidence of this complication. Reports refer to qualitatively different effects, and the extent to which reactions go unreported is unknown". In Australia there had been 57 reports of convulsions to ADRAC up until June 1994. ADRAC also notes two reports of choreoathetosis, two of confusion, four reports of oculogyric crises and eight of oposthotonos up to June 1994. In the U.K. there were 170 reports of convulsions, myoclonus or opisthotonos up until 1992. The Committee on the Safety of Medicines in the United Kingdom estimated the incidence of seizures after propofol as 1 in 47,000 administrations 1o . The anaesthetic literature from 1987-92 contained 37 reports of neurological excitatory events lO •
PropoJol: An Anti-convulsant
The bulk of available evidence supports the general concept that in most circumstances, propofol is an anticonvulsant. Studies in mice 26 . 28 suggest that propofol has comparable efficacy to thiopentone in preventing experimentally induced seizures. Propofol has Anaesthesia and Intensive Care, Vot. 22 , No. 6, December, 1994 been used successfully to abort experimental status epilepticus in rabbits 29 as well as to successfully treat status epilepticus in humans 30J2 . Propofol appears to reduce seizure duration when compared with other anaesthetic agents given for electroconvulsive therapy33.37 .
PropoJol-A Pro-convulsant
Many authors have pointed to the difficulty in accepting that a drug with strong evidence of anticonvulsant activity could in certain circumstances be pro-convulsant. Borgeat et al'l suggest that the absence of simultaneous EEG recordings in the presence of abnormal movements in the reported cases leaves the diagnosis in doubt.
Spontaneous movements have long been recognised to be associated with propofol, in animals 38 . 39 as well as in humans 4o ,41. Other intravenous anaesthetic agents, e.g. methohexitone, have also been associated with involuntary movements. An EEG study42 demonstrated a very high incidence of dystonic and choreiform movements in children given propofol. The effect was dose dependent, occurring at the lower of two different induction doses. It was also found to occur in the recovery period 4J . The effect was not associated with EEG changes. This suggested a subcortical effect. Saunders et al performed EEGs on three patients who had opisthotonos after propofol anaesthesia 6 and there was no epileptiform activity on EEG.
Could it be that the wide variety of effects reported as "convulsions" or "seizures" possibly due to propofol, are in fact the extreme edge of a spectrum of effects beginning with "spontaneous movements"? There is little evidence to indicate EEG epileptiform activity in relation to propofol44,45, and other reports suggest no EEG epileptiform effect of propofol even in patients undergoing temporal lobe surgery for epilepsy '6,47. Thus much of the controversy over this matter may reside in how we define what we are observing. Propofol may not be producing, primarily, cortical convulsive activity while producing the outward manifestation that we interpret as seizure activity. It is interesting that the seizure effects of propofol have often been noted to occur during "light" anaesthesia. In his 1937 book Guedel 48 , discussing stages of ether anaesthesia, described a second stage, a stage of excitement or uninhibited response, prior to reaching surgical anaesthesia. Does propofol provide a similar "window" for marked involuntary activity in susceptible patients?
It is also interesting to note that one of the advant-ages quoted for propofol is the brisk return to clear consciousness on emergence from anaesthesia. However, it often appears that patients after propofol are on a "high" or in a state of psychological excitement that may bear some resemblance to the excitement of a pre-delirium state. Perhaps again the convulsions experienced by some patients are merely the extreme end of this frequently observed state of excitement.
Possible Mechanisms
Sustained clonic movements were produced in mice by propofol in one study49. Enhancement of this effect by sub-convulsant doses of strychnine was suggested by the investigators to indicate a possible mechanism for the excitatory effects of propofol-glycine antagonism at sub-cortical levels. Sneyd, in a review of the subject\ suggests that "perhaps propofol has a primary action at or close to the GABA receptor with a much lower level of glycine antagonism responsible for occasional unexpected side-effects such as opisthotonos and myoclonus". It has also been pointed out l3 that propofol has an antidopaminergic action which may be relevant to the effects observed. The authors suggest that "an imbalance between cortical and subcortical effects with propofol" is involved in the genesis of movements l3
• SUMMARY
It is now clear that "seizure activity", excitatory phenomena, and/or a disorder of muscle tone are potential complications of the use of propofo!. Whether this "seizure activity" is primarily, secondarily, or not at all a cerebral cortical event is still to be elucidated. Clearly propofol does have anticonvulsant activity, and also clearly it can produce an involuntary movement disorder, in certain patients, under certain conditions. Propofol is not the first anaesthetic drug to be implicated in the causation of seizures or abnormal movements 9 . IO nor indeed the first to appear to have anti-convulsant and proconvulsant activity (e.g. Althesin).9.1O.
While propofol has undoubtedly proved a very useful drug, the problem of convulsive phenomena creates a degree of background concern about its use. More needs to be known about the mechanism of this complication and any risk factors involved in determining who may have a seizure after propofo!.
In the clinical setting, the reporting of seizures possibly related to propofol should include 5 0-medical history, including personal or family history of epilepsy and movement disorders; a history of previous anaesthetics and whether propofol was used; regular medi-cations; use of drugs or alcohol; history of chemical dependency; emotional state prior to induction; presence of hyperventilation or fever; a description of the alleged seizure, including rate of administration of propofol and amount given, time of onset of seizure in relation to time of drug administration, speed of onset of signs, quality of the abnormal movements, part of body involved, duration, any indication of a postictal state, any cardiovascular changes which may have accompanied the seizure, and any other possible triggers for the reaction such as other drugs used, including premedication; post seizure investigations including temperature, blood sugar, electrolytes, arterial gas analysis, neurological examination, EEG and CT scan.
These actions and these investigations concerning propofol should not be delayed. It would appear appropriate to recommend to patients who experience apparent convulsive phenomena after propofol that they not be re-exposed to the drug.
